Index
Introduction
Dear Fellow Shareholders
Our Products
Product Characteristics
Republic of South Africa Approval
Accredited Medical Education Program
Physician Q&A
Phase III Clinical Trials
U.S. Market Opportunity
Medical Readiness
2001 Highlights
Form 10-K
Biopure Corporate Information
Shareholder Information
Item 9.
Changes In and Disagreements With Accountants on Accounting and Financial Disclosure
Not applicable.
